Keywords: merck, co, turnover, up, vioxx, sales, slowing

Merck & Co turnover up 13% but Vioxx sales are slowing down

Article | 19 October 2001

Print This

Merck & Co has posted a 13% increase in turnover to $11.92 billion forthe third quarter of 2001, while net income climbed 6% to $1.95 billion ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in